Charles Bonnet Syndrome asssociated with glaucoma in a 95-year old female: A case report

Yıl 2024, , 116 - 119, 31.08.2024

Elif Parlak , Suleyman Emre Kocyıgıt

https://doi.org/10.33716/bmedj.1463212

Öz

Vision problems increase with age and evaluation of visual perception is important in geriatric practice. Visual hallucinations may occur in elderly individuals for various reasons. Hallucinations secondary to loss of severe visual acuity or visual field, also known as Charles Bonnet Syndrome(CBS), may be rarely seen. We reported a case of CBS secondary to glaucoma in a 95-year-old female patient. It is stated that this patient's visual hallucination has been developing for the last 3 years. The patient had simple hallucinations that were not related to dementia or psychotic disorder. The patient had accompanying depressive mood and fear of being alone. Visual hallucinations decreased after antidepressant treatment. The oldest known case of CBS is presented.

Anahtar Kelimeler

charles bonnet syndrome, aging, depression, visual hallucinations, glaucoma

95 yaşında kadında glokom ilişkili Charles Bonnet sendromu: Olgu sunumu

Öz

Görme sorunları yaşla birlikte artar ve geriatri pratiğinde görsel algının değerlendirilmesi önemlidir. Yaşlı bireylerde çeşitli nedenlerle görsel halüsinasyonlar ortaya çıkabilmektedir. Charles Bonnet Sendromu (CBS) olarak da bilinen ileri derecede görme keskinliği veya görme alanı kaybına bağlı halüsinasyonlar nadiren görülebilmektedir. Biz 95 yaşında kadın hastada glokomun neden olduğu CBS olgusunu bildirdik. Bu hastanın son 3 yıldır görsel varsanılarının geliştiği ifade edilmektedir. Hastanın demans veya psikotik bozuklukla ilgisi olmayan basit halüsinasyonları mevcuttur. Tabloya depresif duygu durumu ve yalnız kalma korkusu da eşlik etmekteydi. Antidepresan tedavisinden sonra görsel halüsinasyonlar azalmıştır. Bilinen en yaşlı CBS vakası sunulmuştur.

Anahtar Kelimeler

charles bonnet sendromu, yaşlanma, depresyon, görsel halüsinasyonlar, glokom

Kaynakça

• Banerjee, A. K., Falkai, P. G., & Savidge, M. (1989). Visual hallucinations in the elderly associated with the use of levodopa. Postgraduate Medical Journal, 65(764), 358-361.
• Bergman, Y., & Barak, Y. (2013). Escitalopram for antipsychotic nonresponsive visual hallucinosis: eight patients suffering from Charles Bonnet syndrome. International psychogeriatrics, 25(9), 1433-1436.
• Caamaño-Ponte, J., Gómez Digón, M., Pereira Pía, M., de la Iglesia Cabezudo, A., Echevarría Canoura, M., & Facal, D. (2021). A case study on polypharmacy and depression in a 75-year-old woman with visual deficits and charles bonnet syndrome. Geriatrics, 7(1), 5.
• El Haj, M., Roche, J., Jardri, R., Kapogiannis, D., Gallouj, K., & Antoine, P. (2017). Clinical and neurocognitive aspects of hallucinations in Alzheimer’s disease. Neuroscience & Biobehavioral Reviews, 83, 713-720.
• Elflein, H. M., Rudy, M., Lorenz, K., Ponto, K., Scheurich, A., & Pitz, S. (2016). Charles Bonnet’s syndrome: not only a condition of the elderly. Graefe's Archive for Clinical and Experimental Ophthalmology, 254, 1637-1642.
• Fischer, C. E., Namasivayam, A., Crawford-Holland, L., Hakobyan, N., Schweizer, T. A., Munoz, D. G., & Pollock, B. G. (2022). Psychotic disorders in the elderly: diagnosis, epidemiology, and treatment. Psychiatric Clinics, 45(4), 691-705.
• Jan, T., & Del Castillo, J. (2012). Visual hallucinations: charles bonnet syndrome. Western Journal of Emergency Medicine, 13(6), 544.
• Jones, L., Ditzel-Finn, L., Enoch, J., & Moosajee, M. (2021). An overview of psychological and social factors in Charles Bonnet syndrome. Therapeutic Advances in Ophthalmology, 13, 25158414211034715.
• Kaya, D., Dokuzlar, O., Kaya, M., Soysal, P., & Isik, A. T. (2020). An elderly patient with Charles Bonnet syndrome misdiagnosed as Lewy Body dementia. Acta Neurologica Belgica, 120, 1011-1013.
• Kester, E. M. (2009). Charles Bonnet syndrome: case presentation and literature review. Optometry-Journal of the American Optometric Association, 80(7), 360-366.
• Lang, U. E., Stogowski, D., Schulze, D., Domula, M., Schmidt, E., GaLLinat, J., Tugtekin, S. M., & Felber, W. (2007). Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. Journal of Psychopharmacology, 21(5), 553-555.
• Le, J. T., Peprah, D., Agrón, E., Keenan, T. D., Clemons, T. E., & Chew, E. Y. (2022). Associations between Age-Related Eye Diseases and Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2: Report Number 26. Ophthalmology, 129(2), 233-235.
• Pang, L. (2016). Hallucinations experienced by visually impaired: Charles Bonnet syndrome. Optometry and Vision Science, 93(12), 1466-1478.
• Sanford, A. M. (2018). Lewy body dementia. Clinics in geriatric medicine, 34(4), 603-615.
• Schadlu, A. P., Schadlu, R., & Shepherd III, J. B. (2009). Charles Bonnet syndrome: a review. Current opinion in ophthalmology, 20(3), 219-222.
• Seeburg, D. P., Liu, X., & Chen, C. (2004). Frequency-dependent modulation of retinogeniculate transmission by serotonin. Journal of Neuroscience, 24(48), 10950-10962.
• Subedi, B., & Grossberg, G. T. (2011). Phantom limb pain: mechanisms and treatment approaches. Pain research and treatment, 2011(1), 864605.
• Teunisse, R. J., Zitman, F. G., Cruysberg, J., Hoefnagels, W., & Verbeek, A. (1996). Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. The Lancet, 347(9004), 794-797.
• Wilkinson, F. (2004). Auras and other hallucinations: windows on the visual brain. Progress in brain research, 144, 305-320.